STK Short Volume
Columbia Seligman Premium Technology Growth Fund (STK) operates in the Financial Services sector, specifically the Asset Management industry, with a market capitalization near $953.7M, listed on NYSE, carrying a beta of 1.62 to the broader market. Columbia Seligman Premium Technology Growth Fund is a closed ended equity mutual fund launched and managed by Columbia Management Investment Advisers, LLC. Led by William F. Truscott, public since 2009-11-27.
Short volume measures the number of shares sold short on a given day as reported by FINRA. Tracking short volume relative to total volume helps identify unusual bearish sentiment or short-squeeze potential.
- Latest Date
- 2026-06-01
- Short Volume
- 7.9K
- Total Volume
- 28.1K
- Short %
- 28.04%
- 30-Day Avg Short %
- 43.47%
Showing 30 days of FINRA short volume data for Columbia Seligman Premium Technology Growth Fund.
Learn how short volume is reported and how to read the data →
Frequently asked STK short volume questions
- What is the daily STK short volume?
- As of Jun 1, 2026, Columbia Seligman Premium Technology Growth Fund (STK) short volume is 7.9K shares against 28.1K total reported volume, or 28.04% short-side. Short volume measures shares sold short during the day; it is flow, not inventory.
- How is STK short volume reported?
- FINRA publishes the Daily Short Sale Volume File for trades reported to FINRA TRFs and the FINRA/Nasdaq ADF on a T+1 basis. The headline figure is the count of shares that printed at the short-sale or short-exempt tick across all reporting venues for the symbol; each exchange separately publishes its own daily short-sale data file.
- What does STK short volume tell options traders?
- Daily short-sale flow is one input that helps disambiguate dealer-hedging activity from directional bear flow when the chain shows fresh customer call inventory. It is not a clean MM-only proxy: the headline number mixes directional shorting, options-MM delta-hedging, ETF-creation arbitrage, and convertible-arb hedging. Cross-check against gamma-exposure and OI changes for a cleaner read.